Finance

Lists
Why is 300878 down 2,47%?
Dive Deeper
300878:SHE
Zhejiang Wecome Pharmaceutical Co Ltd
CNÂ¥27,69
-2,47%
(-0,70) 1D
15 Okt., 15:04:25 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300878...
Open
CNÂ¥28,20
High
CNÂ¥28,84
Low
CNÂ¥27,50
Mkt. cap
4,19 mjd
Avg. vol.
2,35 m
Volume
1,48 m
52-wk high
CNÂ¥40,22
52-wk low
CNÂ¥20,30
EPS
-CNÂ¥1,28
Shares outstanding
144,79 m
No. of employees
535
Open
CNÂ¥28,20
High
CNÂ¥28,84
Low
CNÂ¥27,50
Mkt. cap
4,19 mjd
Avg. vol.
2,35 m
Volume
1,48 m
52-wk high
CNÂ¥40,22
52-wk low
CNÂ¥20,30
EPS
-CNÂ¥1,28
Shares outstanding
144,79 m
No. of employees
535
News stories
From web sources and news partners
About Zhejiang Wecome Pharmaceutical Co Ltd
CEO-
Employees535
Founded31 Mrt. 2000
Headquarters-
SectorPharmaceutical industry
Websitezjwk.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
36,75 m
73,95 m
69,66 m
56,50 m
Cost of goods sold
33,52 m
56,94 m
28,21 m
50,14 m
Cost of revenue
33,52 m
56,94 m
28,21 m
50,14 m
Research and development expenses
1,67 m
1,71 m
2,07 m
2,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31,87 m
42,25 m
26,23 m
28,80 m
Operating expense
27,62 m
63,68 m
31,26 m
29,87 m
Total operating expenses
61,14 m
120,62 m
59,48 m
80,01 m
Operating income
-24,39 m
-46,66 m
10,18 m
-23,51 m
Other non operating income
-29,48 k
53,88 k
325,30 k
-339,00 k
EBT including unusual items
-55,73 m
-96,46 m
5,72 m
-26,21 m
EBT excluding unusual items
-26,03 m
-46,98 m
6,22 m
-21,50 m
Income tax expense
3,78 m
9,45 m
3,88 m
-2,16 m
Effective tax rate
-6,78%
-9,79%
67,78%
8,23%
Other operating expenses
-3,99 m
8,98 m
221,88 k
985,04 k
Net income
-59,63 m
-103,49 m
1,74 m
-24,00 m
Net profit margin
-162,28%
-139,93%
2,50%
-42,48%
Earnings per share
-
-
-
-
Interest and investment income
260,87 k
248,04 k
1,37 m
2,43 m
Interest expense
-1,88 m
-614,40 k
-5,66 m
-74,55 k
Net interest expenses
-1,62 m
-366,36 k
-4,29 m
2,36 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,82 m
-31,58 m
25,27 m
-11,83 m
Gain or loss from assets sale
-493,86 k
992,60 k
-
-4,36 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme